2024-12-11
Artivila Biopharma Announces Clearances of IND Applications for ARD-885 by Chine
ShenZhen, Guangdong, China. December 11, 2024- Artivila Biopharma today announced that the Chinese National Medical Products Administration (NMPA) and the United States Food and Drug Administration (FDA) have approved its Investigational New Drug (IND) ap
Read more